Ladenburg Thalmann Expands Investment Banking Platform with Biotechnology Specialist Dr. Aydin Huseynov, M.D., CFA
Ladenburg Thalmann & Co. Inc. (“Ladenburg Thalmann”), a leading middle-market investment bank providing investment banking, equity research, and institutional sales and trading services, today announced that Aydin Huseynov, M.D., CFA, has joined the firm's Healthcare Investment Banking Group as Managing Director, Biotechnology Investment Banking Specialist.
